Screening pelvic examinations in asymptomatic, average-risk adult women: An evidence report for a clinical practice guideline from the American college of physicians

Annals of Internal Medicine

Volumn 161, Issue 1, 2014, Pages 46-53

  Bloomfield, Hanna E ^a,b   Olson, Andrew ^a,c   Greer, Nancy ^a,b   Cantor, Amy ^a,d   MacDonald, Roderick ^a,b   Rutks, Indulis ^a,b   Wilt, Timothy J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Minneapolis Veterans Affairs Health Care System   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ASYMPTOMATIC DISEASE; ATROPHIC VAGINITIS; BLADDER CANCER; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEAR; FEMALE; HUMAN; INTERMEDIATE RISK POPULATION; OVARY CANCER; PAPANICOLAOU TEST; PELVIC EXAMINATION; PELVIC INFLAMMATORY DISEASE; PELVIC PAIN; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING; SEXUAL VIOLENCE; UTERUS CANCER; VAGINA CANCER; VERRUCA VULGARIS; VULVA CARCINOMA; WOMEN'S HEALTH;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC ERRORS; FEMALE; GENITAL DISEASES, FEMALE; GYNECOLOGICAL EXAMINATION; HUMANS; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; PAIN; RAPE; RISK FACTORS;

EID: 84903574085     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-2881     Document Type: Review

References (62)

1. Stormo AR, Hawkins NA, Cooper CP, Saraiya M. The pelvic examination as a screening tool: practices of US physicians [Letter]. Arch Intern Med. 2011;171: 2053-4. [PMID: 22158576]
2. Committee on Gynecologic Practice. Committee opinion no. 534: well-woman visit. Obstet Gynecol. 2012;120:421-4. [PMID: 22825111]
3. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA. 2001;285:2232-9. [PMID: 11325325] (Pubitemid 32416769)
4. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep. 2002;51(RR-15):1-38. [PMID: 12418541]
5. Meyers DS, Halvorson H, Luckhaupt S; U.S. Preventive Services Task Force. Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147:135-42. [PMID: 17576995] (Pubitemid 351664618)
6. Schoeman SA, Stewart CM, Booth RA, Smith SD, Wilcox MH, Wilson JD. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ. 2012;345:e8013. [PMID: 23236032]
7. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep. 2011;60:370-3. [PMID: 21451447]
8. Moyer VA; U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880-91. [PMID: 22711081]
9. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-72. [PMID: 22422631]
10. Reitsma JB, Rutjes AW, Whiting P, Vlassov VV, Leeflang MM, Deeks JJ. Chapter 9: Assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0.0. Birmingham, United Kingdom: The Cochrane Collaboration; 2009. Accessed at http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/ ch09-Oct09.pdf on 8 May 2013.
11. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. [PMID: 14606960]
12. Grover SR, Quinn MA. Is there any value in bimanual pelvic examination as a screening test. Med J Aust. 1995;162:408-10. [PMID: 7746172]
13. Jacobs I, Stabile I, Bridges J, Kemsley P, Reynolds C, Grudzinskas J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1:268-71. [PMID: 2893084] (Pubitemid 18052262)
14. Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DE. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 1996;65:221-5. [PMID: 8730628] (Pubitemid 26101489)
15. Stewart RA, Thistlethwaite J, Evans R. Pelvic examination of asymptomatic women - attitudes and clinical practice. Aust Fam Physician. 2008;37:493-6. [PMID: 18523709]
16. Golomb D. Attitudes toward pelvic examinations in two primary care settings. R I Med J. 1983;66:281-4. [PMID: 6577533]
17. Harper C, Balistreri E, Boggess J, Leon K, Darney P. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect. 2001;33:13-8. [PMID: 11271540]
18. Bourne PA, Charles CA, Francis CG, South-Bourne N, Peters R. Perception, attitude and practices of women towards pelvic examination and Pap smear in Jamaica. N Am J Med Sci. 2010;2:478-86. [PMID: 22558551]
19. Hesselius I, Lisper HO, Nordström A, Anshelm-Olson B, Odlund B. Comparison between participants and non-participants at a gynaecological mass screening. Scand J Soc Med. 1975;3:129-38. [PMID: 1215854]
20. Wijma B, Gullberg M, Kjessler B. Attitudes towards pelvic examination in a random sample of Swedish women. Acta Obstet Gynecol Scand. 1998;77:422-8. [PMID: 9598951] (Pubitemid 28181913)
21. Armstrong L, Zabel E, Beydoun HA. Evaluation of the usefulness of the 'hormones with optional pelvic exam' programme offered at a family planning clinic. Eur J Contracept Reprod Health Care. 2012;17:307-13. [PMID: 22524280]
22. Osofsky HJ. Women's reactions to pelvic examination. Obstet Gynecol. 1967;30:146-51. [PMID: 6027483]
23. Hoyo C, Yarnall KS, Skinner CS, Moorman PG, Sellers D, Reid L. Pain predicts non-adherence to pap smear screening among middle-aged African American women. Prev Med. 2005;41:439-45. [PMID: 15917039] (Pubitemid 40732358)
24. Taylor VM, Yasui Y, Burke N, Nguyen T, Acorda E, Thai H, et al. Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers Prev. 2004;13:613-9. [PMID: 15066927] (Pubitemid 38737898)
25. Fiddes P, Scott A, Fletcher J, Glasier A. Attitudes towards pelvic examination and chaperones: a questionnaire survey of patients and providers. Contraception. 2003;67:313-7. [PMID: 12684154] (Pubitemid 36398517)
26. Yu CK, Rymer J. Women's attitudes to and awareness of smear testing and cervical cancer. Br J Fam Plann. 1998;23:127-33. [PMID: 9882766]
27. Broadmore J, Carr-Gregg M, Hutton JD. Vaginal examinations: women's experiences and preferences. N Z Med J. 1986;99:8-10. [PMID: 3456108] (Pubitemid 16123254)
28. Haar E, Halitsky V, Stricker G. Patients' attitudes toward gynecologic examination and to gynecologists. Med Care. 1977;15:787-95. [PMID: 895235] (Pubitemid 8208146)
29. Petravage JB, Reynolds LJ, Gardner HJ, Reading JC. Attitudes of women toward the gynecologic examination. J Fam Pract. 1979;9:1039-45. [PMID: 521765]
30. Kahn JA, Goodman E, Huang B, Slap GB, Emans SJ. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic. Obstet Gynecol. 2003;101:490-9. [PMID: 12636952] (Pubitemid 36288488)
31. Amy NK, Aalborg A, Lyons P, Keranen L. Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes (Lond). 2006;30:147-55. [PMID: 16231037] (Pubitemid 41790791)
32. Adams CH, Smith NJ, Wilbur DC, Grady KE. The relationship of obesity to the frequency of pelvic examinations: do physician and patient attitudes make a difference? Women Health. 1993;20:45-57. [PMID: 8372479] (Pubitemid 23235959)
33. Lee TT, Westrup DA, Ruzek JI, Keller J, Weitlauf JC. Impact of clinician gender on examination anxiety among female veterans with sexual trauma: a pilot study. J Womens Health (Larchmt). 2007;16:1291-9. [PMID: 18001185] (Pubitemid 350125858)
34. Weitlauf JC, Finney JW, Ruzek JI, Lee TT, Thrailkill A, Jones S, et al. Distress and pain during pelvic examinations: effect of sexual violence. Obstet Gynecol. 2008;112:1343-50. [PMID: 19037045]
35. Weitlauf JC, Frayne SM, Finney JW, Moos RH, Jones S, Hu K, et al. Sexual violence, posttraumatic stress disorder, and the pelvic examination: how do beliefs about the safety, necessity, and utility of the examination influence patient experiences? J Womens Health (Larchmt). 2010;19:1271-80. [PMID: 20509787]
36. Robohm JS, Buttenheim M. The gynecological care experience of adult survivors of childhood sexual abuse: a preliminary investigation. Women Health. 1996;24:59-75. [PMID: 9046553] (Pubitemid 27102067)
37. Farley M, Golding JM, Minkoff JR. Is a history of trauma associated with a reduced likelihood of cervical cancer screening? J Fam Pract. 2002;51:827-31. [PMID: 12401150]
38. Watson-Johnson LC, Townsend JS, Basile KC, Richardson LC. Cancer screening and history of sexual violence victimization among U.S. adults. J Womens Health (Larchmt). 2012;21:17-25. [PMID: 22011207]
39. Hilden M, Sidenius K, Langhoff-Roos J, Wijma B, Schei B. Women's experiences of the gynecologic examination: factors associated with discomfort. Acta Obstet Gynecol Scand. 2003;82:1030-6. [PMID: 14616277] (Pubitemid 37311040)
40. Lang AJ, Rodgers CS, Laffaye C, Satz LE, Dresselhaus TR, Stein MB. Sexual trauma, posttraumatic stress disorder, and health behavior. Behav Med. 2003;28:150-8. [PMID: 14663922] (Pubitemid 37474272)
41. Leeners B, Stiller R, Block E, Görres G, Imthurn B, Rath W. Effect of childhood sexual abuse on gynecologic care as an adult. Psychosomatics. 2007;48:385-93. [PMID: 17878496] (Pubitemid 47333885)
42. Morgan RJ Jr, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, et al National Comprehensive Cancer Network. Ovarian cancer, version 3.2012. J Natl Compr Canc Netw. 2012;10:1339-49. [PMID: 23138163]
43. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. Committee Opinion No. 477: the role of the obstetriciangynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011;117:742-6. [PMID: 21343791]
44. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011;61:8-30. [PMID: 21205832]
45. Moyer VA; U.S. Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157:900-4. [PMID: 22964825]
46. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al PLCO Project Team. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305:2295-303. [PMID: 21642681]
47. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10:327-40. [PMID: 19282241]
48. Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol. 2006;18:503-10. [PMID: 16932044] (Pubitemid 44319022)
49. Stacey CM, Munday PE. Abdominal pain in women attending a genitourinary medicine clinic: who has PID? Int J STD AIDS. 1994;5:338-42. [PMID: 7819351] (Pubitemid 24301523)
50. Munday PE. Pelvic inflammatory disease - an evidence-based approach to diagnosis. J Infect. 2000;40:31-41. [PMID: 10762109] (Pubitemid 30157771)
51. Blake DR, Fletcher K, Joshi N, Emans SJ. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol. 2003;16:25-30. [PMID: 12604142] (Pubitemid 36330406)
52. Soper DE. Pelvic inflammatory disease. Obstet Gynecol. 2010;116:419-28. [PMID: 20664404]
53. Centers for Disease Control and Prevention. Sexually transmitted diseases - treatment guidelines, 2010: pelvic inflammatory disease. Atlanta, GA: Centers for Disease Control and Prevention; 2010. Accessed at www.cdc.gov/std/ treatment/2010/pid.htm on 14 June 2013.
54. Fisher LD, Fletcher KE, Blake DR. Can the diagnosis of pelvic inflammatory disease be excluded without a bimanual examination? Clin Pediatr (Phila). 2004;43:153-8. [PMID: 15024438] (Pubitemid 38299071)
55. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete? J Womens Health (Larchmt). 2011;20:5-10. [PMID: 21194307]
56. Stormo AR, Cooper CP, Hawkins NA, Saraiya M. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med. 2012;54:415-21. [PMID: 22484240]
57. Henderson JT, Harper CC, Gutin S, Saraiya M, Chapman J, Sawaya GF. Routine bimanual pelvic examinations: practices and beliefs of US obstetriciangynecologists. Am J Obstet Gynecol. 2013;208:109.e1-7. [PMID: 23159688]
58. Perkins RB, Anderson BL, Gorin SS, Schulkin JA. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Am J Prev Med. 2013;45:175-81. [PMID: 23867024]
59. Berkowitz Z, Saraiya M, Sawaya GF. Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing [Letter]. JAMA Intern Med. 2013;173:922-4. [PMID: 23568334]
60. LeFevre ML. Swimming upstream: doing less in health care is hard: comment on "No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease" and "Cervical cancer screening intervals, 2006 to 2009". JAMA Intern Med. 2013;173:856-8. [PMID: 23568453]
61. Mehrotra A, Zaslavsky AM, Ayanian JZ. Preventive health examinations and preventive gynecological examinations in the United States. Arch Intern Med. 2007;167:1876-83. [PMID: 17893309] (Pubitemid 47481483)
62. Morioka-Douglas N, Hillard PJ. No Papanicolaou tests in women younger than 21 years or after hysterectomy for benign disease. JAMA Intern Med. 2013;173:855-6. [PMID: 23568165]